NCT05913063Recruiting
Direct Discrimination of Quantum States by the Human Eye
Direct Discrimination of Quantum States by the Human Eye With Macular Degeneration
Source: ClinicalTrials.gov · Last updated 18 Mar 2026
Brief summary (registry, in English)
Age-related macular degeneration (AMD), is a debilitating eye disease that causes a loss of central vision. The prevalence of AMD increases exponentially with age and causes a significant impact through both medical expenses and the social and economic costs associated with vision loss. AMD is the global leading cause of blindness among people over the age of 60. Detection of this eye disease at early stages coupled with prompt treatment can prevent vision loss; however, modern diagnosis methods are ineffective at diagnosis of AMD before vision loss occurs. While a range of available treatment options has been effective at slowing vision loss due to AMD, no treatment exists which can recover lost vision. The investigators propose to apply tools developed in quantum information science to diagnose AMD before vision has been affected, drastically improving health outcomes for patients with AMD.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 50 (estimated)
- First submitted
- 31 May 2023
- Start date
- 26 Jun 2023
- Primary completion date
- 1 Jul 2029
- Lead sponsor
- Centre for Eye and Vision Research
- Diseases
- Macular degeneration
- NCT number
- NCT05913063
What you commit to
- Study type: Interventional
- Planned participants: 50
- From 26 Jun 2023 to the primary completion date, 1 Jul 2029
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Participants with any additional eye diagnosis or condition
Who the study is looking for
- Participants who are clinically diagnosed with a vision disease affecting their macula
- Older adults who are matched for age.
- Participants who are clinically diagnosed with glaucoma
- Participants who have normal vision.
- One aged-matched control with normal vision will be recruited for each of the diagnosed groups (born in the same year).
Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Centre for Eye and Vision Research Limited Coordinator of this site? Confirm its status | Hong Kong | Hong Kong SAR China | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.